Reinforcing the relevance of the TGF-β signalling for malignant tumours, inhibition of this molecular pathway has been shown to prevent the progression of many types of cancers in mouse models by reducing the phenotypic plasticity of cancer cells [27,30]. Here, TGFB1 is linked to cancer.